These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 32643975)
1. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population. Bekmez S; Eris E Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975 [No Abstract] [Full Text] [Related]
2. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086 [TBL] [Abstract][Full Text] [Related]
3. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227 [TBL] [Abstract][Full Text] [Related]
4. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949 [TBL] [Abstract][Full Text] [Related]
5. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study. Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. Ghanem RC; Vargas JF; Ghanem VC Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789 [TBL] [Abstract][Full Text] [Related]
13. In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis. Aydamirov AS; Harbiyeli II; Ozturk G; Yarkin F; Erdem E; Yagmur M Int Ophthalmol; 2023 May; 43(5):1701-1710. PubMed ID: 36346478 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis. Schuhman G; Vidic B J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164 [TBL] [Abstract][Full Text] [Related]
15. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis. Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529 [TBL] [Abstract][Full Text] [Related]
16. Correlation between corneal involvement and anterior chamber flare in epidemic keratoconjunctivitis. Kiyat P; Palamar M; Yilmaz SG; Emre S Eur J Ophthalmol; 2020 Sep; 30(5):897-900. PubMed ID: 31111724 [TBL] [Abstract][Full Text] [Related]
17. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis. Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319 [TBL] [Abstract][Full Text] [Related]